Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.21) per share which met the analyst consensus estimate. This is a 38.24 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $369.000 thousand which beat the analyst consensus estimate of $172.125 thousand by 114.38 percent. This is a 33.70 percent increase over sales of $276.000 thousand the same period last year.